Latest Sydney News

Tivan Limited has engaged ICA Natural Resources to lead the debt financing phase for its Speewah Fluorite Project, advancing the path to a Final Investment Decision amid secured equity backing and ongoing feasibility work.

Iris Cairns Property Trust has waived all remaining conditions on its $3.87 per unit takeover bid for Reef Casino Trust, securing 80.97% ownership and setting a firm 14 August close date.

Dome Gold Mines (ASX:DME) is raising up to AUD 2 million through unsecured convertible notes to accelerate its Sigatoka feasibility study, mining lease application, and copper-gold exploration amid rising metal prices.

Evolution Mining plans to release its FY26 financial results on 19 August, highlighting 715koz gold and 66kt copper production with robust cash flow and cost metrics.

WAM Income Maximiser (ASX: WMX) has kicked off a $125.4 million entitlement offer priced at $1.62 per share, alongside a $47 million placement, aiming to bolster its capital base while maintaining a 7.1% fully franked dividend yield.

JPMorgan Asset Management has revised the estimated cash distributions for its four Equity Premium Income Complex ETFs for August 2026, with payments scheduled mid-month.

Charter Hall Social Infrastructure REIT (ASX:CQE) reported a 13.1% rise in operating earnings per unit for FY26, driven by strategic acquisitions and strong rental growth, while raising guidance for FY27.

FortifAI’s NOL8 AI Data Plane has proven its scalability and economic edge in global live tests across the Megaport network, outperforming legacy software by a wide margin in data governance and latency.

Transurban has sealed a landmark toll reform agreement with the NSW Government, featuring toll reductions, two-way tolling on the Eastern Distributor, and a government-funded M7-M2 motorway widening aimed at easing Sydney congestion.

Ashley Services Group has finalised its acquisition announced in June, expanding its weekly workforce to over 10,000 during peak seasons and reinforcing its position in the labour hire sector.

Australian Rare Earths (ASX: AR3) has delivered a standout Pre-Feasibility Study and maiden Ore Reserve for its Koppamurra project, underpinning a low-capital, high-return rare earths development. Meanwhile, pilot processing advances and a new niobium-REE discovery at Overland add momentum.

Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.